AxoGen Company

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.
Technology: Other
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Investors Number: 8
Total Funding: $515.5M
Estimated Revenue: $10M to $50M
Last Funding Type: Series G

Visit Website
Register and Claim Ownership